A strategy for generating mutations in histone genes at their endogenous location in Saccharomyces cerevisiae is presented.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
A strategy for generating mutations in histone genes at their endogenous location in Saccharomyces cerevisiae is presented.
We describe a PCR- and homologous recombination-based system for generating targeted mutations in histone genes in budding yeast cells. The resulting mutant alleles reside at their endogenous genomic sites and no exogenous DNA sequences are left in the genome following the procedure. Since in haploid yeast cells each of the four core histone proteins is encoded by two non-allelic genes with highly homologous open reading frames (ORFs), targeting mutagenesis specifically to one of two genes encoding a particular histone protein can be problematic. The strategy we describe here bypasses this problem by utilizing sequences outside, rather than within, the ORF of the target genes for the homologous recombination step. Another feature of this system is that the regions of DNA driving the homologous recombination steps can be made to be very extensive, thus increasing the likelihood of successful integration events. These features make this strategy particularly well-suited for histone gene mutagenesis, but can also be adapted for mutagenesis of other genes in the yeast genome.
The four core histone proteins H2A, H2B, H3, and H4 play central roles in the compaction, organization, and function of eukaryotic chromosomes. Two sets of each of these histones form the histone octamer, a molecular spool that directs the wrapping of ~147 base pairs of DNA around itself, ultimately resulting in the formation of a nucleosome1. Nucleosomes are active participants in a variety of chromosome-based processes, such as the regulation of gene transcription and the formation of euchromatin and heterochromatin across chromosomes, and as such have been the focus of intense research over the course of the past several decades. A number of....
Access restricted. Please log in or start a trial to view this content.
NOTE: The experimental strategy for targeted in situ histone gene mutagenesis includes several steps (summarized in Figure 1). These steps include: (1) Replacement of the target histone gene with the URA3 gene, (2) Generation and purification of PCR products corresponding to two partially overlapping fragments of the target histone gene using primers harboring the desired mutation(s), (3) Fusion PCR of the two partially overlapping fragments to obtain full size PCR products for integration, (4) Co-transformation of full size PCR products and backbone plasmid, and selection for marker on plasmid, (5) Screen for 5-FOA-resistant transfo....
Access restricted. Please log in or start a trial to view this content.
We describe the generation of an hht2 allele expressing a histone H3 mutant protein harboring a substitution at position 53 from an arginine to a glutamic acid (H3-R53E mutant) as a representative example of the targeted in situ mutagenesis strategy.
We generated a strain in which the entire ORF of HHT2 is replaced by the URA3 gene (see step 1 of the protocol). This strain, yAAD156, also harbo.......
Access restricted. Please log in or start a trial to view this content.
The high level of sequence homology between the two non-allelic genes that code for each of the four core histone proteins in haploid S. cerevisiae cells can represent a challenge for investigators who wish to specifically target one of the two genes for mutagenesis. Previously described yeast mutagenesis methodologies, including the Delitto Perfetto, site-specific genomic (SSG) mutagenesis, and cloning-free PCR-based allele replacement methods5,6
Access restricted. Please log in or start a trial to view this content.
The authors declare that they have no competing financial interests.
We thank Reine Protacio for helpful comments during the preparation of this manuscript. We express our gratitude to the National Science Foundation (grants nos. 1243680 and 1613754) and the Hendrix College Odyssey Program for funding support.
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| 1 kb DNA Ladder (DNA standards) | New England BioLabs | N3232L | |
| Agarose | Sigma | A5093-100G | |
| Boric Acid | Sigma | B0394-500G | |
| dNTP mix (10 mM each) | ThermoFisher Scientific | R0192 | |
| EDTA solution (0.5 M, pH 8.0) | AmericanBio | AB00502-01000 | |
| Ethanol (200 Proof) | Fisher Scientific | 16-100-824 | |
| Ethylenediaminetetraacetic acid disodium salt dihydrate (EDTA) | Sigma | E4884-500G | |
| Lithium acetate dihydrate | Sigma | L6883-250G | |
| MyCycler Thermal Cycler | BioRad | 170-9703 | |
| Poly(ethylene glycol) (PEG) | Sigma | P3640-1KG | |
| PrimeSTAR HS DNA Polymerase (high fidelity DNA polymerase) and 5x buffer | Fisher Scientific | 50-443-960 | |
| Salmon sperm DNA solution | ThermoFisher Scientific | 15632-011 | |
| Sigma 7-9 (Tris base, powder form) | Sigma | T1378-1KG | |
| Sodium acetate trihydrate | Sigma | 236500-500G | |
| Supra Sieve GPG Agarose (low metling temperature agarose) | AmericanBio | AB00985-00100 | |
| Taq Polymerase and 10x Buffer | New England BioLabs | M0273X | |
| Toothpicks | Fisher Scientific | S67859 | |
| Tris-HCl (1 M, pH 8.0) | AmericanBio | AB14043-01000 | |
| a-D(+)-Glucose | Fisher Scientific | AC170080025 | for yeast media |
| Agar | Fisher Scientific | DF0140-01-0 | for yeast media |
| Peptone | Fisher Scientific | DF0118-07-2 | for YPD medium |
| Yeast Extract | Fisher Scientific | DF0127-17-9 | for YPD medium |
| 4-aminobenzoic acid | Sigma | A9878-100G | for complete minimal dropout medium |
| Adenine | Sigma | A8626-100G | for complete minimal dropout medium |
| Glycine hydrochloride | Sigma | G2879-100G | for complete minimal dropout medium |
| L-Alanine | Sigma | A7627-100G | for complete minimal dropout medium |
| L-Arginine monohydrochloride | Sigma | A5131-100G | for complete minimal dropout medium |
| L-Asparagine monohydrate | Sigma | A8381-100G | for complete minimal dropout medium |
| L-Aspartic acid sodium salt monohydrate | Sigma | A6683-100G | for complete minimal dropout medium |
| L-Cysteine hydrochloride monohydrate | Sigma | C7880-100G | for complete minimal dropout medium |
| L-Glutamic acid hydrochloride | Sigma | G2128-100G | for complete minimal dropout medium |
| L-Glutamine | Sigma | G3126-100G | for complete minimal dropout medium |
| L-Histidine monohydrochloride monohydrate | Sigma | H8125-100G | for complete minimal dropout medium |
| L-Isoleucine | Sigma | I2752-100G | for complete minimal dropout medium |
| L-Leucine | Sigma | L8000-100G | for complete minimal dropout medium |
| L-Lysine monohydrochloride | Sigma | L5626-100G | for complete minimal dropout medium |
| L-Methionine | Sigma | M9625-100G | for complete minimal dropout medium |
| L-Phenylalanine | Sigma | P2126-100G | for complete minimal dropout medium |
| L-Proline | Sigma | P0380-100G | for complete minimal dropout medium |
| L-Serine | Sigma | S4500-100G | for complete minimal dropout medium |
| L-Threonine | Sigma | T8625-100G | for complete minimal dropout medium |
| L-Tryptophan | Sigma | T0254-100G | for complete minimal dropout medium |
| L-Tyrosine | Sigma | T3754-100G | for complete minimal dropout medium |
| L-Valine | Sigma | V0500-100G | for complete minimal dropout medium |
| myo-Inositol | Sigma | I5125-100G | for complete minimal dropout medium |
| Uracil | Sigma | U0750-100G | for complete minimal dropout medium |
| Ammonium Sulfate | Fisher Scientific | A702-500 | for complete minimal dropout medium |
| Yeast Nitrogen Base | Fisher Scientific | DF0919-07-3 | for complete minimal dropout medium |
| 5-Fluoroorotic acid (5-FOA) | AmericanBio | AB04067-00005 | for 5-FOA medium |
Access restricted. Please log in or start a trial to view this content.